Live from the NIH registry
Studies recruiting near Fargo right now
Top 25 of 206 recruiting studies, sorted by proximity — each links to its official registry page
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Obesity or Overweight
Phase 3
Interventional 2,500 participants sought
Research Site — Fargo, North Dakota (2.0 mi)
· Sponsor: AstraZeneca
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities
Periprosthetic Joint Infections
N/A
Interventional 204 participants sought
Sanford South University Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Elute, Inc.
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Children's Oncology Group
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
Atopic Dermatitis (AD), Psoriasis (PsO)
Phase 1
Interventional 48 participants sought
Red River Research Partners — Fargo, North Dakota (2.0 mi)
· Sponsor: LAPIX Therapeutics Inc.
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Lung Non-Small Cell Carcinoma
Phase 3
Interventional 336 participants sought
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Retroperitoneal Sarcoma, Liposarcoma
Phase 3
Interventional 250 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 1
Interventional 24 participants sought
Red River Research Partners — Fargo, North Dakota (2.0 mi)
· Sponsor: Incyte Corporation
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 0065) — Fargo, North Dakota (2.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Sanford Health - Fargo — Fargo, North Dakota (2.0 mi)
· Sponsor: Novo Nordisk A/S
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Red River Research Partners - Fargo- Site Number : 8400037 — Fargo, North Dakota (2.0 mi)
· Sponsor: Sanofi
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
B Acute Lymphoblastic Leukemia Associated With Down Syndrome, Down Syndrome
N/A
Observational 330 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Children's Oncology Group
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Malignant Neoplasm
Phase 1, Phase 2
Interventional 134 participants sought
Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 4003) — Fargo, North Dakota (2.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Healthy Adult Participants
N/A
Observational 15 participants sought
Decentralized / At-Home Participation (U.S.) — Fargo, North Dakota (2.0 mi)
· Sponsor: Ecotera Health LLC
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Sanford Health- Fargo — Fargo, North Dakota (2.0 mi)
· Sponsor: American Society of Clinical Oncology
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: PedAL BCU, LLC
Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
Age-related Wet Macular Degeneration
Phase 1
Interventional 45 participants sought
CBCC Global Research Site:003 — Fargo, North Dakota (2.0 mi)
· Sponsor: Caregen Co. Ltd.
Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Phase 1
Interventional 25 participants sought
Clinical Site 11 — Fargo, North Dakota (2.0 mi)
· Sponsor: Corvus Pharmaceuticals, Inc.
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Sanford Broadway Medical Center — Fargo, North Dakota (2.0 mi)
· Sponsor: NRG Oncology
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota (2.0 mi)
· Sponsor: NRG Oncology
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Red River Research Partners — Fargo, North Dakota (2.0 mi)
· Sponsor: Incyte Corporation
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
Pyoderma Gangrenosum
Phase 3
Interventional 90 participants sought
Red River Research Partners, LLC — Fargo, North Dakota (2.0 mi)
· Sponsor: LEO Pharma
The Minimalist Trial-2
HPV-Related Oropharynx Squamous Cell Carcinoma
Phase 2
Interventional 142 participants sought
Sanford Roger Maris Cancer Center — Fargo, North Dakota (2.0 mi)
· Sponsor: Washington University School of Medicine